Content related to Precision Medicine for Pediatric Cancer

Research performed over the last several decades has led to an increased understanding of the genetics of cancer. The clinical application of this knowledge for pediatric cancer has lagged behind

Children’s Hospital Los Angeles (CHLA) and Thermo Fisher Scientific have agreed to develop a next-generation sequencing (NGS)-based panel designed specifically for pediatric cancer research. The assay

Peter Chiarelli, MD, DPhil, is combining chemistry, physics and nanoscience to find new therapies for diffuse intrinsic pontine gliomas.